title: [Usefulness of P53 oncoprotein in urinary wash cytology: experience in patients with superficial bladder carcinoma].
abstract: OBJECTIVE
  1) To determine p53 expression in urinary wash cytology by immunohistochemistry in patients with superficial transitional cell carcinoma of the bladder and controls; 2) to correlate p53 in urinary wash cytology and anatomopathological characteristics of the bladder tumors analyzed; 3) to determine the utility of p53 expression in urinary wash cytology as a prognostic factor; and 4) to identify a subgroup of patients with superficial tumors of worse prognosis in order to improve control of the evolution of the tumor and treatment.
  
  
  METHODS
  From 1993 to 1998, 141 cases were studied; 32 controls comprised group I and 109 (38 primary and 71 recurrence) patients with transitional cell carcinoma of the urinary bladder comprised group II.
  
  
  RESULTS
  In group II, 29.5% were positive for p53 in urinary wash cytology, while no positive cases were found in group I. A total of 104 valid data were analyzed, which showed a higher percentage of p53-positive cases in grade III tumors (44.4%). Statistical analysis showed the percentage of p53-positive cases increased with tumor grade in a linear trend (p = 0.17). The recurrence rate in the p53-positive was 20% greater than in the p53-negative cases. Tumor progression was three times higher in the p53-positive than in the p53-negative patients.
  
  
  CONCLUSIONS
  The application of biomolecular knowledge to cytology is a useful complement in follow-up of patients with superficial transitional cell carcinoma of the bladder and offers additional parameters to distinguish benign and malignant cells. Immunohistochemical determination of p53 in urinary wash cytology identifies patients with superficial tumors with a worse prognosis.
authors.affiliation: Servicio de Urología, Hospital Clínico San Carlos, Madrid, España.
authors.forename: J
authors.initials: J
authors.lastname: Moreno Sierra
authors.forename: S
authors.initials: S
authors.lastname: Luengo Alpuente
authors.forename: J
authors.initials: J
authors.lastname: López García-Asenjo
authors.forename: E
authors.initials: E
authors.lastname: Redondo González
authors.forename: E
authors.initials: E
authors.lastname: Blanco Jiménez
authors.forename: C
authors.initials: C
authors.lastname: Fernández Pérez
authors.forename: A
authors.initials: A
authors.lastname: Silmi Moyano
authors.forename: L
authors.initials: L
authors.lastname: Resel Estévez
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002295:Carcinoma, Transitional Cell / Q000473:pathology* / Q000652:urine*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D016159:Tumor Suppressor Protein p53 / Q000652:urine*; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000652:urine*
chemical_list: D016159:Tumor Suppressor Protein p53